Global pharmaceutical sector is constantly evolving due to unmet medical needs, growing generic market, keen focus on healthcare costs, introduction of new drugs etc. are acting as catalysts. Pharmaceutical metered nasal spray systems or devices are here around for more than 40 years. These are used as treatment for illnesses such as nasal jamming, allergic rhinitis, where more than 300 million sufferers are there worldwide. Intensifying air pollution problems making increase in respiratory diseases. Increased industrialization and growing number of vehicles are major factors contributing to these diseases. The electronic nasal spray device market has witnessed many new product launches in recent few years, e.g. Aptar Pharma, an international manufacturer of drug delivery systems, has launched first integrated electronic nasal spray lockout device (e-Lockout) called “Instanyl DoseGuard” and received the approval by European Medicines Agency (EMA). The device/package has been developed in partnership with Takeda Pharmaceuticals.
Growing awareness about respiratory related devices & air pollution in major cities across the globe is driving the electronic nasal spray device market. Tech savvy millennial population are demanding smart solutions for health related problems. Today as the semiconductor technology becoming cheaper which is expected to help the electronic nasal spray device market. Growing middle class population and disposable income levels are helping the electronic nasal spray device market expand at healthy growth rates. Manual or mechanical nasal pumps or nasal spray dispensers are cheap but not efficient in terms of dosage accuracy and keeping count of dosages on a daily basis. Electronic nasal spray devices in contrast to manual nasal spray dispensers are more accurate and more efficient.
Electronic nasal spray dispensers also helps in keeping count of dosages, which helps in avoiding the habit making for dosages and maintain proper patient dosage prescriptions. Increasing government regulations on medical devices & healthcare sector on approvals from authorized industry bodies, exports, imports etc. are expected to restrain the growth of electronic nasal spray device market growth with average impact. The research & development investments in medical systems industry have grown twofold in the last decade, which is expected to positively impact on the electronic nasal spray device market.
The electronic nasal spray devices market is segmented on the basis of technology and end-use. On the basis of technology, the global electronic nasal spray devices market is segmented into unit dose systems, and multi dose systems. Based on the end use global electronic nasal spray devices market is segmented into child electronic nasal spray devices and adult electronic nasal spray devices. The child electronic nasal spray device market is expected to dominate the global market by end use. Multi dose electronic nasal spray device segment is expected to dominate the overall market by technology. Overall the market is expected to expand at a lucrative compound annual growth rate (CAGR).
Electronic nasal spray devices market has been segmented on the basis of region into North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Middle East & Africa (MEA), and Japan. North America is expected to dominate the overall global electronic nasal spray devices market, with U.S. as a major contributor. This is due to United States dominating medical device & healthcare market. Western Europe is expected to stand at second place by electronic nasal spray devices market. France, Germany & U.K are major contributors in Western Europe. China is driving the APEJ electronic nasal spray devices market. Eastern Europe & Latin America are expected to pose attractive market opportunity during the forecast period. APEJ emerging economies growing middle class population, economic growth and rising awareness about health care is expected to drive the region’s electronic nasal spray device market.
Some of the players in the global electronic nasal spray devices market are Aptar Group, Catalent, Inc., Air Liquide Group, Curida AS, Lanaform SA, Safety 1st and others.
Request For Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-5723